• Investment opportunities
    • All opportunities
  • Investor
    • How does it work?
    • Why invest with Capital Cell?
    • Secondary market
    • Our portfolio
    • Invite a friend
    • Risk warning
    • Due diligence
    • What is Marketpay
    • Claims
    • Frequently Asked Questions
  • Company
    • Fundraising round in Capital Cell
    • Phases of a round
    • Share your project
    • Our portfolio
    • BioExpert Network
    • Due diligence
    • What is Marketpay
    • Frequently Asked Questions
  • Blog
  • About us
  • EN
      • ES
      • EN
      • FR
      • IT
      • DE
      • NL
      • SV
  • Register
  • Login
  • Investment opportunities
    • All opportunities
  • Investor
    • How does it work?
    • Why invest with Capital Cell?
    • Secondary market
    • Our portfolio
    • Invite a friend
    • Risk warning
    • Due diligence
    • What is Marketpay
    • Claims
    • Frequently Asked Questions
  • Company
    • Fundraising round in Capital Cell
    • Phases of a round
    • Share your project
    • Our portfolio
    • BioExpert Network
    • Due diligence
    • What is Marketpay
    • Frequently Asked Questions
  • Blog
  • About us
  • EN
      • ES
      • EN
      • FR
      • IT
      • DE
      • NL
      • SV
  • Register
  • Login

Welcome

Login and fund life

Forgot your password?

Not a member? Join today

Nothing is poison everything is poison

  • Home
  • Posts by␣ Daniel Oliver Uriel
  • Apr 24, 2025
  • Biotechnology, Science, Risks

Nothing is poison everything is poison

By Daniel Oliver

  • Apr 10, 2025
  • Investment

The Real Estate Junkies

By Daniel Oliver

  • Apr 7, 2025
  • Investment, Health

Big Pharma vs. the Drug Cartels

By Daniel Oliver

  • Mar 28, 2025
  • Biotechnology, Investment, Health

It ain't no Miracle, it's just Biology

By Daniel Oliver

  • Mar 21, 2025
  • Science, Investment, Health

"This will be a great year for investors" - again

By Daniel Oliver

  • Mar 14, 2025
  • Biotechnology, Investment

Rare diseases: From Orphan to Investor Darling

By Daniel Oliver

  • Mar 7, 2025
  • Investment

The 2.6 Billion Dollar Pill

By Daniel Oliver

  • Mar 3, 2025
  • Investment

Not 11, not 30: 50.

By Daniel Oliver

  • Feb 21, 2025
  • Investment, Health

Natural Resistance (to Innovation)

By Daniel Oliver

  • Feb 14, 2025
  • Science
  • No comments

It's Science, Stupid

By Daniel Oliver

Keep up to date with all our investment opportunities

Contact

Contact us if you have any doubts. We will be happy to help you.

info@capitalcell.net

+(34) 93 100 42 87

+(33) 17 095 05 53

Address

CAPITAL CELL ESPAÑA
C. Sant Antoni Maria Claret 167
Recinte Modernista Sant Pau, Pavelló Sant Manel, Oficina 1.9
08025, Barcelona, España
CAPITAL CELL FRANCIA
8 Rue Jean Antoine de Baïf
75013, Paris, Francia

 

Capital Cell is an authorized and supervised and supervised by the Comisión Nacional del Mercado de Valores (Spanish Securities and Exchange Commission) with license PFP nº17 and license ECSP (European Crowdfunding Service Provider).

Links

  • Register for free
  • Academy for Investors
  • FAQs
  • Conditions of use general
  • Privacy Policy privacy
  • Cookie Usage Policy cookies
  • Warning about investment investment risks
  • Conditions applicable to promoters
This site uses cookies to improve your experience
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always on
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE AND ACCEPT